Payment overview · 2025
General Payments
$79.24
4 reported records · 1 companies
Healthcare provider profile · identity verified
David S Abernathy, M. D.
Allopathic & Osteopathic Physicians|Internal Medicine · MORGANTON, NC · NPI 1265497366
Verified facts
What the public records show
CMS Open Payments records show David S Abernathy, M. D. received $79.24 in general payments during 2025 across 4 reported records.
Alkermes, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $79.24 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $79.24 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ARISTADA Normalized: aristada |
Drug | Alkermes, Inc. | $79.24 | 4 | 2025 |
Source payment records
|
|||||
| LYBALVI Normalized: lybalvi |
Drug | Alkermes, Inc. | $79.24 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 892 | 216 |
| Amlodipine Besylate | Amlodipine Besylate | 758 | 192 |
| Lisinopril | Lisinopril | 578 | 152 |
| Omeprazole | Omeprazole | 543 | 134 |
| Levothyroxine Sodium | Levothyroxine Sodium | 532 | 119 |
| Losartan Potassium | Losartan Potassium | 505 | 132 |
| Gabapentin | Gabapentin | 344 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 313 | 82 |
| Sertraline Hcl | Sertraline Hcl | 309 | 67 |
| Carvedilol | Carvedilol | 295 | 67 |
| Eliquis | Apixaban | 287 | 53 |
| Furosemide | Furosemide | 285 | 57 |
| Metformin Hcl | Metformin Hcl | 282 | 70 |
| Spironolactone | Spironolactone | 273 | 59 |
| Tramadol Hcl | Tramadol Hcl | 268 | 51 |
| Prednisone | Prednisone | 224 | 109 |
| Metoprolol Succinate | Metoprolol Succinate | 216 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 213 | 52 |
| Jardiance | Empagliflozin | 208 | 43 |
| Montelukast Sodium | Montelukast Sodium | 206 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 198 | 46 |
| Trazodone Hcl | Trazodone Hcl | 187 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 184 | 57 |
| Allopurinol | Allopurinol | 183 | 40 |
| Metoprolol Tartrate | Metoprolol Tartrate | 176 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 48 |
| Pantoprazole Sodium | Pantoprazole Sodium | 171 | 39 |
| Lorazepam | Lorazepam | 169 | 35 |
| Alendronate Sodium | Alendronate Sodium | 164 | 47 |
| Ezetimibe | Ezetimibe | 163 | 36 |
| Potassium Chloride | Potassium Chloride | 157 | 37 |
| Meloxicam | Meloxicam | 148 | 38 |
| Ozempic | Semaglutide | 139 | 20 |
| Pregabalin | Pregabalin | 138 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 128 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 127 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 121 | 36 |
| Farxiga | Dapagliflozin Propanediol | 119 | 17 |
| Simvastatin | Simvastatin | 118 | 35 |
| Buspirone Hcl | Buspirone Hcl | 116 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 115 | 25 |
| Famotidine | Famotidine | 113 | 25 |
| Clonazepam | Clonazepam | 109 | 17 |
| Donepezil Hcl | Donepezil Hcl | 109 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 97 | 26 |
| Metformin Hcl Er | Metformin Hcl | 91 | 31 |
| Glimepiride | Glimepiride | 90 | 27 |
| Mirtazapine | Mirtazapine | 88 | 14 |
| Myrbetriq | Mirabegron | 87 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 86 | 24 |
| Finasteride | Finasteride | 85 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 81 | 21 |
| Entresto | Sacubitril/Valsartan | 77 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 76 | 19 |
| Benazepril Hcl | Benazepril Hcl | 74 | 12 |
| Estradiol | Estradiol | 72 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 71 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 30 |
| Synthroid | Levothyroxine Sodium | 66 | 21 |
| Bupropion Xl | Bupropion Hcl | 65 | 15 |
| Xarelto | Rivaroxaban | 60 | suppressed |
| Alprazolam | Alprazolam | 57 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 17 |
| Memantine Hcl | Memantine Hcl | 57 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 24 |
| Ipratropium Bromide | Ipratropium Bromide | 55 | 18 |
| Valsartan | Valsartan | 55 | 17 |
| Warfarin Sodium | Warfarin Sodium | 55 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 54 | 11 |
| Ondansetron Odt | Ondansetron | 53 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 53 | 13 |
| Rybelsus | Semaglutide | 53 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 51 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 51 | 48 |
| Temazepam | Temazepam | 50 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 49 | suppressed |
| Ramipril | Ramipril | 49 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 47 | 12 |
| Lidocaine | Lidocaine | 47 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 47 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 47 | suppressed |
| Atenolol | Atenolol | 44 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 40 | 33 |
| Lovastatin | Lovastatin | 39 | suppressed |
| Repatha Sureclick | Evolocumab | 39 | suppressed |
| Azithromycin | Azithromycin | 37 | 34 |
| Amoxicillin | Amoxicillin | 36 | 33 |
| Sucralfate | Sucralfate | 36 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 35 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 33 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | 11 |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Nystatin | Nystatin | 29 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Cephalexin | Cephalexin | 26 | 21 |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Nitroglycerin | Nitroglycerin | 24 | 17 |
| Dexlansoprazole Dr | Dexlansoprazole | 22 | suppressed |
| Lubiprostone | Lubiprostone | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Naproxen | Naproxen | 21 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 20 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 20 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 20 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 15 |
| Nadolol | Nadolol | 19 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 19 | 17 |
| Anastrozole | Anastrozole | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | 13 |
| Meclizine Hcl | Meclizine Hcl | 18 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Telmisartan | Telmisartan | 18 | suppressed |
| Torsemide | Torsemide | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 12 |
| Febuxostat | Febuxostat | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Nyamyc | Nystatin | 17 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Gemtesa | Vibegron | 16 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | suppressed |
| Praluent Pen | Alirocumab | 15 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 15 | suppressed |
| Testosterone | Testosterone | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 13 | suppressed |
| Multaq | Dronedarone Hcl | 13 | suppressed |
| Phenazopyridine Hcl | Phenazopyridine Hcl | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Effexor Xr | Venlafaxine Hcl | 12 | suppressed |
| Kerendia | Finerenone | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $79.24 · 4 records | Alkermes, Inc. | ARISTADA, LYBALVI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error